New hope for advanced breast cancer? trial tests novel drug duo
Disease control
Ongoing
This early-stage study is testing a new drug, OP-1250, combined with an existing cancer drug, palbociclib, for people with advanced or spreading breast cancer. The main goals are to find the safest dose of the combination and see how the body processes the drugs. Researchers will…
Phase: PHASE1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC